State of the Art in Cystic Fibrosis Pharmacology Optimization of anti-microbials in the treatment of Cystic Fibrosis Pulmonary Exacerbations: III. Executive Summary

Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis

Thorax.

Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F

doi: 10.1136/

RECOMMENDED

Pulmonary Fibrosis

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Cochrane Database Syst Rev.

Smith S, Rowbotham NJ, Charbek E

doi: 10.1002/14651858.

RECOMMENDED

Further Publications

Treatment of pulmonary exacerbations in cystic fibrosis

★ 3 Recommended by Dr Martin Frey, Faculty Member

Curr Opin Pulm Med.

Ng C, Nadig T, Smyth AR, Flume P

doi: 10.1097/MCP.0000000000000730.

Pulmonary Fibrosis

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Chest.

Hong LT, Liou TG, Deka R, King JB, Stevens V, Young DC

doi: 10.1016/j.chest.2018.06.002.

RECOMMENDED

Pulmonary Fibrosis

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

VanDevanter DR, Heltshe SL, Sanders DB, West NE, Skalland M, Flume PA, Goss CH, STOP-OB Study.

doi: 10.1016/j.jcf.2020.08.006.

COMMENTED

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial

Lancet Respir Med.

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR

doi: 10.1016/

RECOMMENDED

Pulmonary Fibrosis

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Cyst Fibros

Nicholson TT, Smith A, McKone EF, Gallagher CG

doi: 10.1016/j.jcf.2021.08.017

RECOMMENDED

Pulmonary Fibrosis

Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial

Am J Respir Crit Care Med.

Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW; OPTIMIZE Study Group

doi: 10.1164/rccm.

RECOMMENDED

Pulmonary Fibrosis

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Thorax

Wildman MJ, O'Cathain A, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J, Buchan I, Mandefield L, Sutton L, Tappenden P, Elliott RA, Hoo ZH, Drabble SJ, Beever D, CFHealthHub Study Team.

doi: 10.1136/thoraxjnl-2021-217594

Related content

Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Treatment of pulmonary exacerbations in cystic fibrosis

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial